Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6,768,178
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
8,191,011
-
Shares change
-
-839,009
-
Total reported value, excl. options
-
$9,750,038
-
Value change
-
-$1,020,609
-
Put/Call ratio
-
6%
-
Number of buys
-
9
-
Number of sells
-
-19
-
Price
-
$1.19
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q2 2024
42 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q2 2024.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,191,011 shares
.
Largest 10 shareholders include Nantahala Capital Management, LLC (2,391,325 shares), Appian Way Asset Management LP (1,375,880 shares), Phoenix Holdings Ltd. (1,126,736 shares), Y.D. More Investments Ltd (980,807 shares), Clal Insurance Enterprises Holdings Ltd (512,175 shares), VANGUARD GROUP INC (363,675 shares), GEODE CAPITAL MANAGEMENT, LLC (301,550 shares), GOLDMAN SACHS GROUP INC (105,768 shares), BlackRock Inc. (105,619 shares), and Clarity Capital Partners LLC (105,008 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.